AFT Pharmaceuticals Limited, together with its subsidiaries, develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally. The company offers patented, branded, and generic drugs; and products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, pain management, skin care, vitamins, supplements, gastrointestinal, dermatology, and hospital. It has a research and development collaboration with Belgium’s Hyloris Pharmaceuticals to develop a novel innovative injectable iron deficiency therapy. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Atkinson, Hartley

Employees

119

Website

www.aftpharm.com

IPO Date

2015-12-21

Headquarters

129 Hurstmere Road, Level 1, Takapuna, Auckland 0622, New Zealand

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

AFT Pharmaceuticals AFT

AFT Pharmaceuticals Earnings Call Summary

AFT Pharmaceuticals Earnings

Transcripts

Events

About AFT Pharmaceuticals Limited

AFT Pharmaceuticals
AFT